Safeguard Surveillance reply to the NYTimes Article (3-31-2021) Safeguard Surveillance's response to clients following a March 30, 2021 New York Times article that criticized their non-diagnostic COVID-19 surveillance testing at New Trier High School. The letter addresses misrepresentations, clarifies that no federal regulations were violated under CMS surveillance testing guidance, explains the distinction between surveillance and diagnostic testing, and cites CMS enforcement discretion policy and published RT-LAMP peer-reviewed research supporting the test's effectiveness. primary file regulatory surveillance Safeguard Surveillance reply to the NYTimes Article (3-31-2021).md regulatory/surveillance/Safeguard Surveillance reply to the NYTimes Article (3-31-2021).md 2021_03_31 **MARKDOWN CONVERSION NOT HUMAN VERIFIED - MAY CONTAIN ERRORS** gdoc docx CC BY 4.0 - https://creativecommons.org/licenses/by/4.0/ 1164 1529 gfile-url xfile-github-download-url pdf-gdrive-url pdf-github-url github-markdown-url github-markdown-download-url web-pdf-url web-slides-url youtube-url web-url